Jan 12, 2009 | Laboratory News, Laboratory Pathology
It may have been adding insult to injury when Quest Diagnostics Incorporated (NYSE:DGX) made the “Five Dumbest Things on Wall Street: Jan. 9” list. After all, this recognition came just hours after the New York Times hit the street with its reporting of Quest’s acknowledgement of inaccurate Vitamin D test results, which itself was based on The Dark Report’s coverage of Quest’s problems that had become public the previous week. “Five Dumbest Things on Wall...
